Introduction {#s1}
============

Vitamin D primarily functions as a regulator of calcium homeostasis and plays a critical role in bone formation and resorption. The discovery of the vitamin D receptor (VDR) in cells of the immune system and the presence of the vitamin D 1α-hydroxylase (Cyp27B1; Cyp) in dendritic cells and macrophage suggested that locally-produced 1,25(OH)~2~D (1,25D) has regulatory autocrine and paracrine properties in the immune system ([@B1], [@B2]). The vitamin D 1α-hydroxylase (Cyp27B1) converts the circulating form of vitamin D, 25(OH)D, to the high affinity VDR binding form, 1,25D \[Supplementary Figure [1](#SM1){ref-type="supplementary-material"}, [@B3]\]. 25(OH)D is a low affinity ligand of the VDR, that in the absence of 1,25D will bind and regulate vitamin D target genes \[Supplementary Figure [1](#SM1){ref-type="supplementary-material"}, [@B4]\]. The VDR bound to 1,25D acts as a transcription factor to regulate the expression of genes with vitamin D response elements in their promoters ([@B5]). Vitamin D metabolism is tightly regulated by a feed-back loop that includes 1,25D/VDR as an inducer of the vitamin D 24-hydroxylase (Cyp24A1) that eliminates the VDR binding activity of both 25(OH)D and 1,25D ([@B6]). Cyp27B1 KO mice accumulate 25(OH)D when they are fed vitamin D containing diets, because of a failure to induce Cyp24A1 \[Supplementary Figure [1](#SM1){ref-type="supplementary-material"}, [@B4]\]. The VDR is constitutively expressed in most immune cells ([@B7], [@B8]). Resting T cells and B cells express low levels of the VDR, which are upregulated following activation ([@B8], [@B9]). Taken together, it is clear that the immune system is a vitamin D target.

1,25D has been shown to suppress Th1/Th17 responses and diseases including experimental inflammatory bowel disease (IBD) [@B10]. Vitamin D deficiency (D-) and VDR deficiency (knockout, KO) exacerbated experimental IBD in multiple models of colitis ([@B11]--[@B13]). The decrease in IL-17 and IFN-γ production and the increase in T reg cells caused by 1,25D both *in vitro* and *in vivo* have been suggested as mechanisms underlying the ability of 1,25D to suppress IBD ([@B14]--[@B16]). Because of the inhibitory effects of 1,25D on Th1 and Th17 cells, infections that require Th1/Th17 cell responses for resistance might be more severe in 1,25D treated mice. However, 1,25D had no effect on the ability of mice to fight either a *Candida albicans* or a *Herpes simplex* virus infection ([@B17]). 1,25D injections inhibited Th17 responses and increased *Citrobacter rodentium* bacterial shedding at d10 post-infection ([@B18]). Conversely, VDR KO mice were more susceptible to infections with *Listeria monocytogenes, Salmonella* and *C. rodentium* than wildtype (WT) mice ([@B19], [@B20]). 1,25D treatment either had no effect or increased susceptibility to infection, while VDR deficiency increased susceptibility to several different pathogens including *Salmonella* and *C. rodentium*. The contradictory effects of 1,25D vs. VDR deficiency on infection may be a result of differential effects of vitamin D on inflammation vs. clearance.

*C. rodentium* is a gram-negative murine bacterial pathogen, and a model of human infection with enterohemorrhagic and enteropathogenic *Escherichia coli* infections. WT mice clear *C. rodentium* infection within 4--5 weeks of infection ([@B21]). CD4+ T cells, B cells, as well as T-dependent IgG responses are required for clearance of *C. rodentium* ([@B21]). IL-22 KO mice develop a lethal infection with *C. rodentium* and IL-22 from ILC3 cells is required for early protection from *C. rodentium* ([@B22]--[@B24]). Th17 cells and production of IL-17 and IL-22 are needed for the host to clear *C. rodentium* infection ([@B25]). In sum, Th17 and ILC3 cells are critical for host resistance to *C. rodentium*.

Here the effect of vitamin D status on mucosal immunity to *C. rodentium* was determined. Mice that could not produce 1,25D (Cyp27B1 knockout, Cyp KO) were used to model severe vitamin D deficiency (Supplementary Figure [1](#SM1){ref-type="supplementary-material"}, D- Cyp KO). In the D- Cyp KO mice, the residual 25(OH)D is not present at high enough concentrations to bind the VDR (Supplementary Figure [1](#SM1){ref-type="supplementary-material"}). D- Cyp KO mice and D- Rag KO mice developed a severe *C. rodentium* infection that resulted in early lethality of the mice. D- WT mice produced some of the high affinity 1,25D ligand from the residual 25(OH)D (Supplementary Figure [1](#SM1){ref-type="supplementary-material"}). D- WT mice took longer to clear a *C. rodentium* infection than vitamin D sufficient (D+) WT and D+ Cyp KO mice. There was no difference in the susceptibility of D+ WT and D+ Cyp KO mice to *C. rodentium*. D- mice had reduced numbers of ILC3 cells that produced IL-22 in the colon compared to D+ mice. In addition, the expansion of colonic Th17 cells that make IL-17 and IL-22 were lower following *C. rodentium* infection in D- mice. 1,25D treatment of D- mice recovered ILC3 cells and increased the rate of *C. rodentium* clearance compared to D- mice. Treatment of D- Cyp KO mice with IL-22 prevented the lethality and treatment of D- WT mice with IL-22 eliminated the need for vitamin D in the clearance of *C. rodentium*. Vitamin D is required for ILC3 derived IL-22 in the colon and the induction of protective Th17 cell expansion following infection. In the absence of vitamin D, mice develop a more severe enteric infection that takes longer to resolve.

Methods {#s2}
=======

Mice
----

C57BL/6 CD19Cre, LckCre, Rag1 KO, and B6.129P2(Cg)- Rorc^tm2Litt/J^ (Rorc^gfp^) mice were originally from the Jackson Laboratories (Bar Harbor, ME) and bred for experiments at the Pennsylvania State University (University Park, PA). C57BL/6 Cyp27B1 (henceforth described as Cyp KO) KO breeders were a gift from Dr. Hector DeLuca (University of Wisconsin, Madison, WI). Rorc^gfp^ mice were crossed with Rag1 KO mice to generate Rorc^gfp^ Rag1 KO mice for cell sorting experiments of intestinal ILCs. VDR^fl/fl^ mice were a gift from Dr. S. Kato (University of Tokyo, Tokyo, Japan) and were crossed with CD19Cre (B-VDR KO) or LckCre (T-VDR KO) mice. VDR^fl/fl^ Cre+ (B-VDR KO or T-VDR KO) and their corresponding VDR^fl/fl^ Cre- littermates (designated as WT) were used for experiments. Mice were fed purified diets made in the lab as described previously that differed only in vitamin D content ([@B26]). To generate D- and D+ mice, breeders were fed diets with or without vitamin D throughout breeding and continued on the same diets throughout the experiments. Experimental mice were Cyp KO and WT littermates from the same D+ or D- breeders (Supplementary Figure [1](#SM1){ref-type="supplementary-material"}, [@B26]. The vitamin D status (25(OH)D levels) of the offspring were measured prior to doing experiments and serum 25(OH)D levels of 10--20ng/mL were used as the cut-off for vitamin D deficiency ([@B26]). For some experiments, 1,25D was added to the D- diets as described ([@B26]). The 1,25D dose was 25 ng/d for mice that weighed 10--18g and 50 ng/d when the mice weighed \>18g as described previously ([@B26]). Some mice received IL-22Fc injections intraperitoneally (100 μg of IL-22Fc (Genentech, South San Francisco, CA) or 100 μg of IgG2a isotype control (LTF-2, BioXCell, West Lebanon, NH) twice a week beginning at d3 post-infection for 2 weeks and a total of 4 doses per mouse as described previously ([@B27]). All of the experimental procedures were approved by the Institutional Animal Care and Use Committee at the Pennsylvania State University (University Park, PA).

Serum 25(OH)D Measurements
--------------------------

Serum 25(OH)D levels were measured by colorimetric assay using a 25(OH)D ELISA Kit (Eagle Biosciences, Nashua, NH), according to manufacturer\'s instructions. The limit of detection was 1.6 ng/mL 25(OH)D.

*C. rodentium* Infection
------------------------

The *C. rodentium* strain ICC169 (nalidixic acid resistant) was a gift of Dr. Gad Frankel (London School of Medicine and Dentistry, London UK). *C. rodentium* was cultured overnight in Luria-Bertani broth with 50 μg/ml nalidixic acid (EMD chemicals, Gibstown, NJ). Mice were orally gavaged with 5 × 10^9^ colony forming units (CFU) of *C. rodentium* in PBS. In some experiments, one dose of vancomycin (20 mg/mL, MP Biomedicals, Solon, OH) was given by oral gavage the day before *C. rodentium* infection. The vancomycin pretreatment increased infectivity without affecting the shedding kinetics of *C. rodentium* ([@B20]). Feces and tissue samples were collected, weighed, homogenized, and serially diluted and plated to determine the CFU ([@B28]). Histopathology of the distal colon was scored blinded on a scale from 0 to 4 (0 = none; 1 = minimal; 2 = mild; 3 = moderate; 4 = extensive) for inflammation and epithelial hyperplasia as previously described ([@B29], [@B30]). Total histology scores were the sum of the inflammation and epithelial hyperplasia scores for a total score from 0 to 8.

*C. rodentium*-Specific Antibody Responses
------------------------------------------

Detection of *C. rodentium*-specific IgA, IgG1, and IgG2c was done by coating plates with 30 μg/ml sonicated *C. rodentium* overnight. Ig were detected using goat anti-mouse detection antibodies and reported as relative units *C. rodentium* specific IgA (Bethly Laboratories), IgG1and IgG2c (BD Biosciences).

Cell Isolation and Flow Cytometry
---------------------------------

Colon LP cells were isolated as described previously and stained for flow cytometry ([@B20]). Briefly, the whole colon was washed, cut into 1-1.5 cm sections, incubated twice in Hanks\' Balanced Salt Solution (HBSS, Sigma-Aldrich, St. Louis, MO) with 5mM EDTA at 37°C and then digested in RPMI-1640 containing 1 mg/ml collagenase type 1 (Worthington, Lakewood, NJ) and 10% FBS at 37°C for 1h in a shaking incubator. The cells were collected from the interface of 40/80% Percoll gradients (Sigma-Aldrich). The fluorescent dye conjugated-antibodies listed below were used for flow cytometry: Anti-CD3 (145-2C11), CD4 (GK1.5) (Biolegend, San Diego, CA), Thy1.2 (30-H12), CD45.2 (104) (BD Biosciences, San Jose, CA), FoxP3 (FJK-16s), RORγt (B2D), IL-22 (IL22JOP), IL-17A (TC11-18H10) (eBioscience, San Diego, CA). For intracellular cytokine staining, cells were stimulated with PMA (0.1 μg/ml, Sigma-Aldrich), ionomycin (0.5 μg/ml, Sigma-Aldrich) in the presence of Brefeldin A (10 μg/ml, Sigma-Aldrich) for 4 h. For IL-22 intracellular staining, mouse recombinant IL-23 (40 ng/ml, R&D systems, Minneapolis, MN) was added to the PMA, ionomycin and Brefeldin A cultures for 4 h. The cells were fixed and permeabilized using kits for intracellular staining (eBioscience) according to the manufacturer\'s instructions. All data were collected on a BD Fortessa LSRII (BD Biosciences) and analyzed with FlowJo software (TreeStar, Ashland, OR).

Real-Time PCR
-------------

A 1 cm sample of the distal colon was used to measure *hprt*, β*-actin, ifn-*γ*, il-17a, il-22, vdr*, and *rorc* by real-time PCR. Total RNA was isolated from 1 cm distal colons of mice using RNeasy Mini kit (Qiagen, Valencia, CA). cDNA was synthesized by using AMV reverse transcriptase (Promega, Madison, WI) and analyzed using the StepOnePlus real-time PCR system (Thermo Fisher Scientific, Waltham, MA). Gene expression was normalized to *Hprt* or β*-actin* amplified and calculated with the ΔΔCt method. The primer sequences are listed in Supplementary Table [1](#SM1){ref-type="supplementary-material"}.

Statistics
----------

Statistical analyses were performed with PRISM software by (GraphPad, La Jolla, CA). Two-tailed Student\'s *t* test or two-way ANOVA with Bonferroni *post-hoc* tests were used for data analyses as indicated. The survival rates were compared by log-rank tests. For all the analyses, *P* values (^\*^ \< 0.05 ^\*\*^ \< 0.01, ^\*\*\*^ \< 0.001, ^\*\*\*\*^ \< 0.0001) were used to indicate significance. Values are the means ± SEM.

Results {#s3}
=======

Vitamin D Deficient Mice Have Increased Susceptibility to *C. rodentium* Infection
----------------------------------------------------------------------------------

There are contradictory effects of 1,25D and VDR deficiency on host resistance to *C. rodentium* ([@B18], [@B20]). Here we determined the effects of dietary vitamin D deficiency on *C. rodentium* susceptibility. Cyp27B1 is the enzyme that produces high affinity 1,25D from the precursor 25(OH)D (Supplementary Figure [1](#SM1){ref-type="supplementary-material"}). Feeding Cyp KO mice D+ diets results in the accumulation of 25(OH)D in the serum, because of a failure to induce Cyp24A1 (Supplementary Figures [1](#SM1){ref-type="supplementary-material"}, [4](#SM1){ref-type="supplementary-material"}). As expected, the 25(OH)D concentration in the D+ Cyp KO mice was significantly higher than in the D+ WT mice fed the same D+ diets (Figure [1A](#F1){ref-type="fig"}). The kinetics of *C. rodentium* infection in D+ Cyp KO and D+ WT mice were indistinguishable with a peak of infection at d7-14 and then clearance by d35 (Figure [1B](#F1){ref-type="fig"}). D- mice had serum 25(OH)D values \< 20 ng/mL that confirmed their D- status (Figure [1A](#F1){ref-type="fig"}). The D- WT mice had low 25(OH)D levels (Supplementary Figure [1](#SM1){ref-type="supplementary-material"}, Figure [1A](#F1){ref-type="fig"}) in the serum that could still be made into some of the high affinity 1,25D. The D- Cyp KO mice had low 25(OH)D (Supplementary Figure [1](#SM1){ref-type="supplementary-material"}, Figure [1A](#F1){ref-type="fig"}) and were unable to produce any 1,25D that resulted in the complete absence of VDR binding ligands and severe vitamin D deficiency. D- Cyp KO mice developed an acute *C. rodentium* infection that resulted in a significant loss of body weight and premature death of the D- Cyp KO mice (Figures [1B--D](#F1){ref-type="fig"}). The surviving D- Cyp KO mice were sacrificed (33%) at d14, because of excessive body weight loss (Figure [1D](#F1){ref-type="fig"}). D- WT mice shed significantly more *C. rodentium* at d21 post-infection than D+ mice (Figure [1B](#F1){ref-type="fig"}). The D- WT mice took significantly longer to clear the infection than the D+ mice (Figure [1B](#F1){ref-type="fig"}). Vitamin D deficiency increased the susceptibility of mice to *C. rodentium* infection. At d14 post-infection D+ (Supplementary Figure [2A](#SM1){ref-type="supplementary-material"}) mice had no *C. rodentium* in the spleen or liver, while the amount of *C. rodentium* was significantly higher in both D- WT and D- Cyp KO mice (Supplementary Figure [2A](#SM1){ref-type="supplementary-material"}). Because there were no differences in the D+ Cyp KO and D+ WT kinetics of *C. rodentium* clearance, future experiments combined the groups into one D+ group. For D- mice there were no differences in the histopathology scores between WT and Cyp KO mice at d14 post-infection (Cyp KO sections shown in Supplementary Figure [2B](#SM1){ref-type="supplementary-material"}). Histopathology of the colons from D- mice showed severe inflammation, epithelial hyperplasia and higher histopathology scores than the D+ mice at d14 post-infection (Supplementary Figure [2C](#SM1){ref-type="supplementary-material"}). Severely vitamin D deficient D- Cyp KO developed a fulminating and lethal disease following *C. rodentium* infection.

![Increased susceptibility of D- mice to *C. rodentium* infection. **(A)** Serum 25(OH) D levels in 8 week-old D**+** WT, D+ Cyp KO, D- WT, and D- Cyp KO mice. Values are the mean ± SEM of a total *n* = 6--13 mice/group. Mice were infected with *C. rodentium* and **(B)** fecal shedding of the pathogen was monitored, **(C)** the percent original body weight (BW), and **(D)** the survival rate were plotted vs. days post-infection. The values **(B--D)** represent the mean ± SEM of *n* = 3--5 mice/group and from one representative of two independent experiments. One-way ANOVA with Bonferroni *post-hoc* tests **(A)**, Two-way ANOVA with Bonferroni *post-hoc* tests **(B, C)** and log-rank test **(D)** were used to determine significance. ^\*^*P* \< 0.05, ^\*\*\*\*^*P* \< 0.0001.](fimmu-10-00001-g0001){#F1}

Impaired *C. rodentium*-Specific Antibody Production in D- Mice
---------------------------------------------------------------

The antigen specific antibody response was measured to determine whether antibodies could explain the increased susceptibility of D- mice to *C. rodentium* infection. D+ WT and D+ Cyp KO mice mounted a *Citrobacter*-specific IgG1 and IgG2c response that was detectable at d14 and increased by d28 post-infection (Figures [2A,B](#F2){ref-type="fig"}). D- WT and D- Cyp KO mice had very low *Citrobacter*-specific IgG1 and IgG2c responses at both d14 and d28 post-infection (Figures [2A,B](#F2){ref-type="fig"}) The IgG1 or IgG2c *C. rodentium*-specific response was similar in D+ WT and D+ Cyp KO mice at either d14 or d28 post-infection (Figures [2A,B](#F2){ref-type="fig"}). D- (WT and Cyp KO) mice had significantly lower *Citrobacter*-specific IgG1 and IgG2c titers than the D+ mice at d14 and d28 post-infection (Figures [2A,B](#F2){ref-type="fig"}). There was no increase in the antibody titers from d14 to d28 in D- mice (Figures [2A,B](#F2){ref-type="fig"}). *C. rodentium*-specific fecal IgA levels were not different at d14 in the D+ and D- mice (Figure [2C](#F2){ref-type="fig"}). The fecal IgA levels went up at d28 post-infection in D+ mice but not in D- mice (Figure [2C](#F2){ref-type="fig"}). D- mice have reduced *Citrobacter*-specific antibody responses compared to D+ mice.

![Indirect roles of vitamin D in B cells and T cells for clearance of *C. rodentium*. The amount of *C. rodentium*-specific **(A)** IgG1 and **(B)** IgG2c in the serum. Fecal **(C)** *C. rodentium* specific IgA. D+ WT values at d14 were set at 1 and other values are relative to the D + WT value. Values are from two independent experiments and the mean ± SEM of *n* = 6--8 mice per group. Two-way ANOVA with Bonferroni *post-hoc* tests **(A--C)**. Groups without a common letter differ at the indicated time point, *P* \< 0.05. Fecal shedding of *C. rodentium* in **(D)** WT and B-VDR KO or **(E)** WT and T-VDR KO littermates following *C. rodentium* infection. Values are the mean ± SEM of two combined experiments and *n* = 9--13 mice per group. Significance was determined using two-way ANOVA with Bonferroni *post-hoc* tests. ^\*\*\*\*^*P* \< 0.0001.](fimmu-10-00001-g0002){#F2}

In order to determine whether T cells or B cells were the direct targets of vitamin D, mice with the VDR deleted in B cells (B-VDR KO) or T cells (T-VDR KO) were infected with *C. rodentium*. The shedding curves of B-VDR KO mice and their WT littermates were similar until d14-d18 when the B-VDR KO mice had more *C. rodentium* shed in the feces than WT (Figure [2D](#F2){ref-type="fig"}). There was a significant effect of genotype on the shedding kinetics in WT and B-VDR KO mice (Figure [2D](#F2){ref-type="fig"}). However, WT and B-VDR KO mice both cleared *C. rodentium* by d21 post-infection (Figure [2D](#F2){ref-type="fig"}). The *C. rodentium*-specific IgG1 and IgG2c responses at d14 and d28 post-infection were not different in the WT and B-VDR KO littermates (data not shown). In the WT and T-VDR KO littermates there was no effect of genotype on the shedding of *C. rodentium* (Figure [2E](#F2){ref-type="fig"}). There was no effect of deleting the VDR in T cells and a small effect (higher bacterial loads) of deleting the VDR in B cells on the ability of mice to clear *C. rodentium* infection. The data suggest that vitamin D is not directly regulating T or B cell mediated immune responses to *C. rodentium*.

Higher IL-17 mRNA in the Colons From D- Mice at d14 Post-infection
------------------------------------------------------------------

The distal colon was used as a source of mRNA to determine the effect of vitamin D on several cytokines important for host resistance to *C. rodentium*. Because there were no differences in *C. rodentium* susceptibility between D+ WT and D+ Cyp KO mice, the D+ Cyp KO group was eliminated. Before infection, the mRNA levels for *ifn-*γ, *il-17*, and *il-22* were low and not different in D+ WT, D- WT, and D- Cyp KO mice (Figure [3](#F3){ref-type="fig"}). Infection increased expression of the mRNA for *ifn-*γ, *il-17*, and *il-22* at d14 post-infection in all mice (significant time effect Figures [3A--C](#F3){ref-type="fig"}). *Ifn-*γ and *il-22* were not different between D+ WT, D- WT and D-Cyp KO mice at d14 post-infection (Figures [3A,C](#F3){ref-type="fig"}). At d14 post-infection, *il-17* was significantly lower in D+ WT mice than in D- WT mice (*P* = 0.008) and D- Cyp KO (*P* \< 0.0001) mice (Figure [3B](#F3){ref-type="fig"}). D- WT *il-17* mRNA expression was lower than D- Cyp KO *il-17* mRNA in the d14 infected colon (*P* = 0.08, Figure [3B](#F3){ref-type="fig"}). D- mice had higher amounts of *il-17* mRNA in the distal colon compared to D+ mice.

![Increased expression of IL-17 mRNA in D- colons at d14 post-infection. The expression of mRNA for **(A)** *il-22*, **(B)** *il-17*, and **(C)** *ifn-*γ relative to *hprt* in the distal colon of mice. Values are the mean ± SEM of *n* = 3--5 colons/group and one representative of two independent experiments. Statistical analysis was performed by two-way ANOVA with Bonferroni *post-hoc* tests. ^\*^*P* \< 0.05, ^\*\*^*P* \< 0.01.](fimmu-10-00001-g0003){#F3}

Fewer ILC3 and Th17 Cells and Less IL-22 and IL-17 in the Colon of D- Mice
--------------------------------------------------------------------------

The mRNA expression for *il-17* and *il-22* in the distal colon may not represent protein expression throughout the colon. In addition, the cellular source of the IL-17 and IL-22 is unclear in the mRNA analyses in Figure [3](#F3){ref-type="fig"}. ILC3 cells and Th17 cells that produce IL-17 and IL-22 express RORγt and are critical for clearance of *C. rodentium* ([@B22]--[@B25]). ILC3 and Th17 cells were measured in D+ and D- colon LP. The total numbers of cells, the frequency of T cells, TCRβ+, TCRβ+/CD4+, TCRβ+/CD8+, and TCRβ+/CD8αα were not different in the colon as a result of vitamin D status or genotype (data not shown). ILC3 frequencies (Thy-1+/RORγt+/CD3-) and Th17 frequencies (CD4+/RORγt+/CD3+/FoxP3-) were significantly higher in D+ as compared to D- colon (Figure [4A](#F4){ref-type="fig"}). D- mice had fewer ILC3 in both the SI and colon (Figure [4A](#F4){ref-type="fig"}, Supplementary Figure [3](#SM1){ref-type="supplementary-material"}). The frequencies of Th17 cells were also higher in D+ than D- mice (Figure [4A](#F4){ref-type="fig"}). The number of IL-22 secreting ILC3 cells in the whole colon were higher in D+ than D- mice at d0 and d10 post-infection (Figure [4B](#F4){ref-type="fig"}). The frequencies of IL-17 secreting ILC3s, or Th17 were similar at d0 in D+ and D- colons (Figures [4B,C](#F4){ref-type="fig"}). Infection significantly increased the frequencies of T cells that made IL-22 and IL-17 (significant time effect, Figure [4C](#F4){ref-type="fig"}), but infection had no effect on the frequencies of ILC3 cells that made IL-22 and IL-17 (Figure [4B](#F4){ref-type="fig"}). IL-22 secreting ILC3s were higher in D+ than D- colon before and after infection (Figure [4B](#F4){ref-type="fig"}). T cells that made IL-17 and IL-22 were higher in the D+ vs. D- colon following infection (Figure [4C](#F4){ref-type="fig"}). The mean fluorescence intensity (MFI) of IL-22 was higher in D+ mice (compared to D- mice) at d10 post-infection in both the ILC3 and T cells (Supplementary Figures [4A,B](#SM1){ref-type="supplementary-material"}). Conversely, the IL-17 MFI was significantly lower in the D+ ILC3 than D- ILC3 cells but not different in the D+ and D- T cells (Supplementary Figure [4A](#SM1){ref-type="supplementary-material"}). D- mice had reduced numbers of IL-22 producing ILC3s and T cells in the whole colon than D+ mice. Conversely, in the distal colon there was no effect of vitamin D on mRNA for *il-22* (Figure [3C](#F3){ref-type="fig"}). The discrepancy in IL-22 results is likely due to sampling of only part of the colon in Figure [3](#F3){ref-type="fig"} and the whole colon in Figure [4](#F4){ref-type="fig"}. In addition, the colon of D- mice had fewer ILC3 cells that made more IL-17 than the ILC3 cells in the D+ mice (Supplementary Figure [4A](#SM1){ref-type="supplementary-material"}). Overall the data show that D- mice had less IL-22 from both ILC3 and T cells and less IL-17 from T cells than D+ mice.

![Fewer ILC3 and Th17 cells in the colon of D- mice. Gating examples and frequencies of **(A)** ILC3 (Thy1+RORγt+/CD3-) and Th17 (CD4+RORγt+/CD3+) in the colon of D+ and D- mice. The frequencies of **(B)** ILC3 and **(C)** Th17 cells that secrete IL22 (left) or IL-17 (right). Values are mean ± SEM of two combined experiments and **(A)** ILC3, *n* = 9--15; Th17, *n* = 7--11, and **(B)** *n* = 6--9 mice per group. Significance was determined using two-tailed Student\'s *t* tests **(A)**, two-way ANOVA with Bonferroni *post-hoc* tests **(B,C)**. ^\*^*P* \< 0.05, ^\*\*^*P* \< 0.01, ^\*\*\*^*P* \< 0.001, ^\*\*\*\*^*P* \< 0.0001.](fimmu-10-00001-g0004){#F4}

D- Rag KO Mice Are Highly Susceptible to *C. rodentium* Infection
-----------------------------------------------------------------

ILC3 cells that produce IL-22 are critical in the survival and protection of Rag KO mice from *C. rodentium* ([@B23]). D- Rag KO mice had fewer IL-22 secreting ILC3 cells in the colon than D+ Rag KO (Figure [5A](#F5){ref-type="fig"}). By d2 post-infection both the D+ and D- Rag KO mice were shedding extremely high numbers of *C. rodentium* in the feces (Figure [5B](#F5){ref-type="fig"}). Only 1 out of 7 infected D+ Rag KO mice died from the infection within the first few days of infection (Figure [5C](#F5){ref-type="fig"}). Conversely, 4 of 6 infected D- Rag KO mice died from the infection within the first several days (Figure [5C](#F5){ref-type="fig"}). The mice that died had high numbers of *C. rodentium* in the liver and spleen, confirming that the death was due to the infection. Lethality was significantly higher in D- than D+ Rag KO mice (Figure [5C](#F5){ref-type="fig"}, *P* \< 0.03).

![D- Rag KO mice develop a severe and lethal *C. rodentium* infection. **(A)** IL-22 secreting ILC3 frequencies in the colon of D- and D+ Rag KO mice. **(B)** *C. rodentium* fecal shedding in D+ and D- Rag KO mice. **(C)** Survival curves following *C. rodentium* infection of D+ and D- Rag KO mice. Values are from *n* = 6--7 D+ Rag KO and *n* = 6 D- Rag KO mice of two combined experiments. Significance was determined by two-tailed Student\'s *t* tests **(A)**, two-way ANOVA with Bonferroni *post-hoc* tests **(B)** or log rank tests for **(C)**, ^\*^*P* \< 0.05, ^\*\*^*P* \< 0.01.](fimmu-10-00001-g0005){#F5}

1,25D or IL-22 Treatments Protect D- Mice From *C. rodentium* Infection
-----------------------------------------------------------------------

Experiments were done to determine whether ILC3, and/or IL-22 were important for the protective effects of vitamin D in host resistance to *C. rodentium* infection. ILC3 cells express higher levels of mRNA for the VDR than other intestinal ILCs (Supplementary Figure [4C](#SM1){ref-type="supplementary-material"}). To determine whether 1,25D treatments *in vivo* could recover the ILC3 cell numbers, 1,25D treatments were started in D- mice at 6 weeks of age (Supplementary Figure [4D](#SM1){ref-type="supplementary-material"}) or at 3 weeks of age (Figure [6A](#F6){ref-type="fig"}). D- ILC3 frequencies were significantly lower than D+ values when the 1,25D treatment was started at 6 weeks of age (Supplementary Figure [4D](#SM1){ref-type="supplementary-material"}), but reached D+ ILC3 values when the 1,25D treatment was started at 3 weeks of age (Figure [6A](#F6){ref-type="fig"}). The 1,25D treatment increased frequencies of ILC3 that made IL-22 in D- mice (Figure [6B](#F6){ref-type="fig"}). Infection of the 1,25D treated D- (D- + 1,25D) mice resulted in *C. rodentium* shedding kinetics that were significantly different than both D+ WT and D-WT mice (significant group effect, Figure [6C](#F6){ref-type="fig"}). Treatment of D- mice with an IL-22Fc fusion protein resulted in *C. rodentium* shedding kinetics that were more similar to D+ isotype treated than D- isotype treated mice (Figure [6D](#F6){ref-type="fig"}). Furthermore, the D+ WT and D-WT mice that received IL-22 Fc cleared the infection by d35 when the D- WT isotype treated mice still had 2 logs of *C. rodentium* in the feces (Figure [6D](#F6){ref-type="fig"}). Treating D- Cyp KO mice with IL-22 Fc protected the mice from early lethality (100% survival to d14 post infection) as compared to D- Cyp KO isotype treated mice (data not shown). 1,25D treatment increased IL-22 secreting ILC3 cells in D- mice to D+ levels and improved clearance of *C. rodentium* (Figure [6](#F6){ref-type="fig"}). IL-22 treatment eliminated the effect of vitamin D deficiency on *C. rodentium* clearance (Figure [6](#F6){ref-type="fig"}).

![1, 25D treatment and IL-22 treatment of D- mice resulted in more rapid clearance of *C. rodentium* infection. **(A)** Frequencies of ILC3 cells in the colon of D- mice treated with 1, 25D. **(B)** Frequency of IL-22 secreting ILC3 cells following 1, 25D treatment. *C. rodentium* fecal shedding in D- WT mice treated with **(C)** 1,25D (D- + 1,25D) or **(D)** IL-22 treated (D- + IL-22Fc). Values are mean ± SEM of two combined experiments and **(A)** *n* = 7--19 **(B)** *n* = 8--11 **(C)** *n* = 4 **(D)** *n* = 6--9 mice per group. Significance was determined using two-tailed Student\'s *t* tests **(A,B)**, two-way ANOVA with Tukey *post-hoc* tests **(C,D)**.](fimmu-10-00001-g0006){#F6}
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The increased susceptibility of D- mice to *C. rodentium* infection was due to reduced frequencies of colonic ILC3 and ILC3-derived IL-22. IL-22 treatment of D- WT mice eliminated the need for vitamin D for the clearance of *C. rodentium*. In addition, treating D- Cyp KO mice with IL-22 prevented the lethality of the mice from *C. rodentium*. IL-22 secreting ILC3 are required in Rag KO mice for early survival from *C. rodentium* ([@B23]). The majority of D- Rag KO mice (67%) died within two days of *C. rodentium* infection as compared to only 14% of D+ Rag KO mice. IL-22 is a protective cytokine that regulates epithelial tight junction proteins to enhance gut epithelial integrity and induces antimicrobial factors in the small intestine to control the microbiota ([@B31]--[@B33]). D+ and D- mice have distinct microbial communities, which could be due to reduced IL-22 in D- mice ([@B34]). Vitamin D regulates IL-22 producing ILC3 cells in the intestine.

ILC3 cells are vitamin D targets in the mouse colon. VDR mRNA levels were higher in mouse RORγt+ ILC3 cells from the colon than in other ILC cell populations (Supplementary Figure [4C](#SM1){ref-type="supplementary-material"}). 1,25D treatment of D- mice beginning at 3wks of age was effective for increasing the frequency of ILC3 cells, but starting at 6 weeks of age was not. The timing of the 1,25D mediated effect either suggests that ILC3 cells in the colon are indirect vitamin D targets or that there may be a developmental requirement for vitamin D in ILC3 cells. ILC3 cells in the colon peak by 4wks of age to the levels found in 8 week old mice ([@B35]). ILC3 cells require several transcription factors including T-bet, Notch, Ahr, and RORγt for development ([@B36]). Of the transcription factors important for ILC3 development, there is some evidence that Notch may be a vitamin D target. Vitamin D deficient rats had reduced Notch signaling that resulted in muscle atrophy and decreased myocyte regeneration ([@B37]). The mechanisms by which 1,25D regulates ILC3 and IL-22 could involve induction of Notch, direct regulation of IL-22, regulation of ILC3 development and expansion of ILC3 subsets. These signals by which 1,25D regulates ILC3 cell numbers and the production of IL-22 in the colon should be explored further.

Without antibiotic pretreatment, VDR KO mice were resistant to colonization with *C. rodentium* ([@B20]). The colonization resistance of VDR KO mice was shown to correlate with the presence of more ILC3 cells in the SI \[([@B20]) and Supplementary Figure [3](#SM1){ref-type="supplementary-material"}\]. VDR KO and WT mice had similar frequencies of ILC3 cells in the colon \[([@B20]) and Supplementary Figure [3](#SM1){ref-type="supplementary-material"}\]. The data suggest that ILC3 cells in the colon vs. the SI might be differentially regulated by vitamin D and expression of the VDR. The VDR is a nuclear transcription factor that interacts with co-regulatory proteins in the nucleus. The VDR protein-protein interactions are not dependent on the presence of the vitamin D ligand. Others have shown differences between VDR KO and D- effects in other cell types ([@B38]). In the absence of its ligand, the VDR protein binds β-catenin and Lef1 proteins to form a complex that is involved in Wnt signaling ([@B38]). The vitamin D deficient cells would have the normal protein-VDR interactions, while the VDR KO cells would be missing the co-regulatory functions of the unliganded VDR. Nonetheless, the fact that both the VDR KO and D- ILC3 cell numbers change compared to D+ WT ILC3 suggests a critical role of the VDR and vitamin D in ILC3 tissue development and/or function.

The Th17 cells in the colon of the D- mice failed to expand and there were significantly fewer Th17 cells in the d10 infected colon compared to D+ mice. 1,25D treatments have been shown to inhibit IL-17 *in vitro* and *in vivo* presumably by direct inhibition of IL-17 transcripts ([@B18], [@B39], [@B40]). Confirming a direct role of vitamin D on *il-17* mRNA, D- mice over expressed *il17* mRNA in the distal colon following *C. rodentium* infection and the *il17* mRNA was higher in the D- colon than the D+ colon. The higher *Il17* mRNA in the D- colon (Figure [3](#F3){ref-type="fig"}) could be due to the remaining ILC3 cells in the D- colon producing increased amounts of IL-17 (Supplementary Figure [4A](#SM1){ref-type="supplementary-material"}). T cell derived IL-17 was lower in the infected D- colon than the D+ colon. There was no effect of T-VDR KO on host resistance to *C. rodentium*, and therefore it seems unlikely that the failure of Th17 cells to expand following infection is a direct effect of vitamin D on Th17 cells. Instead, the failure of Th17 cells to expand in the D- mice following *C. rodentium* infection could be related to the reduced ILC3 frequencies. ILC3s express MHC class II molecules that present antigens to T cells ([@B41]). ILC3 mediated antigen presentation has been shown to induce T cell activation and proliferation of T cells ([@B41]). Reduced expansion of Th17 cells following infection of D- mice is likely due to reduced numbers of ILC3 cells important for presenting antigen and inducing proliferation of T cells following activation.

The *Citrobacter*-specific antibody response was lower in D- mice. B cells express the VDR and are vitamin D targets ([@B8]). B-VDR KO and VDR KO mice have hyper Ig-E because of the direct role of vitamin D on IL-10 production by B cells ([@B42], [@B43]). Conversely, 1,25D inhibited B cell proliferation, B cell differentiation into plasma cells and IgE production ([@B44]). Here B-VDR KO mice had normal *Citrobacter*-specific antibody responses and the B-VDR KO mice cleared the *C. rodentium* infection with the same kinetics as their WT littermates. Based on this data in B-VDR KO mice the effects of vitamin D on antibody responses to *C. rodentium* are likely indirect effects of vitamin D on B cells.

Fewer ILC3, and less IL-22 resulted in the increased susceptibility of D- mice to *C. rodentium* infection. 1,25D treatment of D- mice that commenced at 3wks of age recovered the ILC3 frequencies in the colon. The 1,25D treatments and higher frequency of ILC3 cells improved the resistance of the D- mice to *C. rodentium*. Vitamin D was also needed to expand the infection induced Th17 response. IL-22 treatment of D- mice completely eliminated a need for vitamin D in the protection of D- mice from *C. rodentium* infection. ILC3 cells require vitamin D for either development or expansion and as a source of early IL-22. Vitamin D is a critical regulator of ILC3 cells and as a result D- mice have compromised resistance to *C. rodentium* infection of the gastrointestinal tract.
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